NCT03247569View on ClinicalTrials.gov

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions

Atrial Fibrillation

Interventions

DRUG

Edoxaban

Edoxaban according to Package Information (Summary of Product Characteristics (SmPC)).

Trial Locations (6)

40002

Srinagarind Hospital and Queen Sirikit Heart Center of the Northeast, Khon Kaen

Unknown

Bangkok Heart Hospital, Bangkok

Bhumibol Adulyadej Hospital, Bangkok

Bangkok Hospital Chiang Mai, Chiang Mai

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai

Thammasat University Hospital, Pathum Thani

All Listed Sponsors

lead

Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company

INDUSTRY

NCT03247569 - Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF) | Biotech Hunter | Biotech Hunter